MEK1 Transduces the Prion Protein N2 Fragment Antioxidant Effects

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2014 Nov 14

PMID 25391659

Citations 16

Authors

C L Haigh

A R McGlade

S J Collins

Affiliations

Soon will be listed here.

Abstract

The prion protein (PrP(C)) when mis-folded is causally linked with a group of fatal neurodegenerative diseases called transmissible spongiform encephalopathies or prion diseases. PrP(C) normal function is still incompletely defined with such investigations complicated by PrP(C) post-translational modifications, such as internal cleavage, which feasibly could change, activate, or deactivate the function of this protein. Oxidative stress induces β-cleavage and the N-terminal product of this cleavage event, N2, demonstrates a cellular protective response against oxidative stress. The mechanisms by which N2 mediates cellular antioxidant protection were investigated within an in vitro cell model. N2 protection was regulated by copper binding to the octarepeat domain, directing the route of internalisation, which stimulated MEK1 signalling. Precise membrane interactions of N2, determined by copper saturation, and involving both the copper-co-ordinating octarepeat region and the structure conferred upon the N-terminal polybasic region by the proline motif, were essential for the correct engagement of this pathway. The phenomenon of PrP(C) post-translational modification, such as cleavage and copper co-ordination, as a molecular "switch" for activation or deactivation of certain functions provides new insight into the apparent multi-functionality of PrP(C).

Citing Articles

Prion Protein Endoproteolysis: Cleavage Sites, Mechanisms and Connections to Prion Disease.

Castle A, Westaway D J Neurochem. 2025; 169(1):e16310.

PMID: 39874431 PMC: 11774512. DOI: 10.1111/jnc.16310.

Prion Protein: The Molecule of Many Forms and Faces.

Kovac V, Serbec V Int J Mol Sci. 2022; 23(3).

PMID: 35163156 PMC: 8835406. DOI: 10.3390/ijms23031232.

Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Mohammadi B, Song F, Matamoros-Angles A, Shafiq M, Damme M, Puig B Cell Tissue Res. 2022; 392(1):215-234.

PMID: 35084572 PMC: 10113312. DOI: 10.1007/s00441-022-03582-4.

Reduced SOD2 expression does not influence prion disease course or pathology in mice.

Foliaki S, Race B, Williams K, Baune C, Groveman B, Haigh C PLoS One. 2021; 16(11):e0259597.

PMID: 34735539 PMC: 8568125. DOI: 10.1371/journal.pone.0259597.

β-Cleavage of the prion protein in the human eye: Implications for the spread of infectious prions and human ocular disorders.

Chaudhary S, Ashok A, Wise A, Rana N, Kritikos A, Lindner E Exp Eye Res. 2021; 212:108787.

PMID: 34624335 PMC: 8608713. DOI: 10.1016/j.exer.2021.108787.

References

Turnbaugh J, Unterberger U, Saa P, Massignan T, Fluharty B, Bowman F . The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc). J Neurosci. 2012; 32(26):8817-30. PMC: 3433751. DOI: 10.1523/JNEUROSCI.1103-12.2012. View

Beraldo F, Arantes C, Santos T, Queiroz N, Young K, Rylett R . Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J Biol Chem. 2010; 285(47):36542-50. PMC: 2978582. DOI: 10.1074/jbc.M110.157263. View

Kolodziejczak D, Dias B, Zuber C, Jovanovic K, Omar A, Beck J . Prion interaction with the 37-kDa/67-kDa laminin receptor on enterocytes as a cellular model for intestinal uptake of prions. J Mol Biol. 2010; 402(2):293-300. DOI: 10.1016/j.jmb.2010.06.055. View

Brown D, Schulz-Schaeffer W, Schmidt B, Kretzschmar H . Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol. 1997; 146(1):104-12. DOI: 10.1006/exnr.1997.6505. View

Zawlik I, Witusik M, Hulas-Bigoszewska K, Piaskowski S, Szybka M, Golanska E . Regulation of PrPC expression: nerve growth factor (NGF) activates the prion gene promoter through the MEK1 pathway in PC12 cells. Neurosci Lett. 2006; 400(1-2):58-62. DOI: 10.1016/j.neulet.2006.02.021. View

Pauly P, Harris D . Copper stimulates endocytosis of the prion protein. J Biol Chem. 1998; 273(50):33107-10. DOI: 10.1074/jbc.273.50.33107. View

McMAHON H, Mange A, Nishida N, Creminon C, Casanova D, Lehmann S . Cleavage of the amino terminus of the prion protein by reactive oxygen species. J Biol Chem. 2000; 276(3):2286-91. DOI: 10.1074/jbc.M007243200. View

Chen S, Teplow D, Parchi P, Teller J, Gambetti P . Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem. 1995; 270(32):19173-80. DOI: 10.1074/jbc.270.32.19173. View

Chiarini L, Freitas A, Zanata S, Brentani R, Martins V, Linden R . Cellular prion protein transduces neuroprotective signals. EMBO J. 2002; 21(13):3317-26. PMC: 125390. DOI: 10.1093/emboj/cdf324. View

10.

Guillot-Sestier M, Sunyach C, Ferreira S, Marzolo M, Bauer C, Thevenet A . α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β (Aβ)-associated cell death. J Biol Chem. 2011; 287(7):5021-32. PMC: 3281657. DOI: 10.1074/jbc.M111.323626. View

11.

Barros J, Marshall C . Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton. J Cell Sci. 2005; 118(Pt 8):1663-71. DOI: 10.1242/jcs.02308. View

12.

Zanata S, Lopes M, Mercadante A, Hajj G, Chiarini L, Nomizo R . Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 2002; 21(13):3307-16. PMC: 125391. DOI: 10.1093/emboj/cdf325. View

13.

Pflanz H, Vana K, Mitteregger G, Renner-Muller I, Pace C, Kuchenhoff H . Scrapie-infected transgenic mice expressing a laminin receptor decoy mutant reveal a prolonged incubation time associated with low levels of PrPres. J Mol Biol. 2009; 388(4):721-9. DOI: 10.1016/j.jmb.2009.03.045. View

14.

Haigh C, Marom S, Collins S . Copper, endoproteolytic processing of the prion protein and cell signalling. Front Biosci (Landmark Ed). 2010; 15(3):1086-104. DOI: 10.2741/3663. View

15.

Westergard L, Turnbaugh J, Harris D . A nine amino acid domain is essential for mutant prion protein toxicity. J Neurosci. 2011; 31(39):14005-17. PMC: 3227396. DOI: 10.1523/JNEUROSCI.1243-11.2011. View

16.

Klamt F, Dal-Pizzol F, Conte da Frota Jr M, Walz R, Andrades M, Silva E . Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic Biol Med. 2001; 30(10):1137-44. DOI: 10.1016/s0891-5849(01)00512-3. View

17.

Cheng F, Lindqvist J, Haigh C, Brown D, Mani K . Copper-dependent co-internalization of the prion protein and glypican-1. J Neurochem. 2006; 98(5):1445-57. DOI: 10.1111/j.1471-4159.2006.03981.x. View

18.

Zeng F, Watt N, Walmsley A, Hooper N . Tethering the N-terminus of the prion protein compromises the cellular response to oxidative stress. J Neurochem. 2003; 84(3):480-90. DOI: 10.1046/j.1471-4159.2003.01529.x. View

19.

Dron M, Moudjou M, Chapuis J, Salamat M, Bernard J, Cronier S . Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent. J Biol Chem. 2010; 285(14):10252-64. PMC: 2856230. DOI: 10.1074/jbc.M109.083857. View

20.

Fluharty B, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C . An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo. J Biol Chem. 2013; 288(11):7857-7866. PMC: 3597823. DOI: 10.1074/jbc.M112.423954. View